2025-524385-18-00CompletedPhase 1
A Randomised, Open-Label, Single-Centre, Study to Evaluate the Bioequivalence of Lanifibranor
Source: EU CTIS (euclinicaltrials.eu) · Last updated 4 Feb 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 21 Nov 2025
- Start date
- Feb 2026
- Lead sponsor
- Inventiva
- EU CT number
- 2025-524385-18-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 30
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Biotrial | Rennes | France | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.